返回 Agenda
Session 2: Clinical Trials – From Directive to Regulation
Session Chair(s)
Nick Sykes, MS
Policy Advisor
EFPIA, Belgium
This session will review issues related to clinical research, for Day 1 and looking forward. This will summarise what we know, what we still don’t know and what we have to do to be prepared. UK issues vs. EU 27: IMP supply and the complex transition via Brexit and then into the new system.
Speaker(s)
Niall Dickson
NHS Confederation, United Kingdom
Chief Executive
Emma Du Four, MBA
-, United Kingdom
Regulatory and R&D Policy Professional
Emlyn Samuel
Cancer Research UK, United Kingdom
Senior Policy Manager